DOCSLIB.ORG

How American Cancer Society Can Help

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
How American Cancer Society Can Help 8/12/2016 Who We Are & How We Can Help Who We Are Our Mission The American Cancer Society is the nationwide, community-based, voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives, and diminishing suffering from cancer, through research, education, advocacy, and service. 3 1 8/12/2016 Our Footprint 300 offices 6,000 staff HI Guam AK VI PR As of February 10, 2015 4 Our Strength 2.5 million volunteers AK HI GUAM PR VI As of February 10, 2015 5 Our Division Operations Focus: building and nurturing relationships, and tailoring programs to communities Corporate & Health Community Distinguished Partners Systems Engagement 6 2 8/12/2016 Fighting for Everyone For more than 100 years, the American Cancer Society has been fighting cancer in every community. Nearly 2.5 million volunteers in more than 6,000 communities around the globe have joined our fight against cancer. Together, we are the largest community-based voluntary health organization in the world. 7 We help people like Michele, Chris, and Phylecia face cancer. The American Cancer Society and our supporters save lives and help those facing cancer every day. “I was devastated. The next day, I called the American Cancer Society… That made a world of difference to me. ” Watch Michele, Chris, and Phylecia’s stories. 8 Cancer Impact by the Numbers 3 8/12/2016 22% Decline in Cancer Death Rates Since 1991 That’s more than 1.5 million cancer deaths avoided. Today, nearly 500 lives are being saved from cancer each day. Siegel, R. L., Miller, K. D. and Jemal, A. (2015), Cancer statistics, 2015. CA: A Cancer Journal for Clinicians, 65: 5–29. doi:10.3322/caac.21254. 10 Growing Number of Cancer Survivors In the United States, there are 14.5 million cancer survivors. By 2024, there will be almost 19 million. 20 18.9 15 14.5 10 Survivors – In Millions 5 3.3 1970 1975 1980 1985 1990 1995 2000 2005 2010 2015 2020 2025 American Cancer Society, Cancer Treatment and Survivorship Facts & Figures 2014-2015, Atlanta; American Cancer Society, 2014 11 There’s Still More Work To Do Cancer Touches Cancer Costs Cancer is a Growing Us All Us So Much Problem Around the World 6 IN 10 Have had immediate family or In the US each year, an estimated Globally each year, an estimated close friends with cancer.1 1.6 million new cancer cases & 14.1 million new cases & 589,000 cancer-related deaths.2 8.2 million deaths.3 1 IN 4 Has served as a caregiver to Cancer costs Americans Lung cancer – a largely someone with cancer.1 $88.7 billion per year in preventable cancer – causes direct medical costs.2 1 in 5 deaths worldwide.3 1. ACS Market Research: 2013 Brand Tracker | 2. American Cancer Society, Cancer Facts & Figures 2015, Atlanta: American Cancer Society; 2015 | 3. The Cancer Atlas, 2nd Edition 12 4 8/12/2016 What We Do The Power of Research Research – The Heart Of Our Mission The American Cancer Society funds both intramural and extramural research. Thanks to the generosity of individual and corporate supporters, the Society has invested more than $4.3 billion in research since 1946 – more than any other private, nonprofit funder of cancer research in the US. We have played a role in most major cancer research breakthroughs in recent history. 15 5 8/12/2016 Extramural Research Grants in Effect as of March 2015 WA ME 18 1 842 Grants MT ND VT Nationwide 7 MN 2 OR NY NH MA 100 17 WI 8 84 19 ID SD MI RI 1 WY 28 PA CT 18 IA 46 NJ 6 NE 6 OH NV 2 IL IN 30 DE 2 1 13 UT 43 WV MD 21 CO 12 KY 1 VA 7 DC 8 CA 16 KS MO 13 108 4 19 NC 43 TN 16 OK SC 8 AZ NM 1 AR 7 3 GA MS AL 11 13 LA AK TX 2 HI 57 FL GUAM 19 PR VI As of March 1, 2015 16 Targeted Research Funding Investigators are engaged in cancer research and training at medical schools, universities, research institutes, and hospitals throughout the US. Following rigorous and independent peer review, the most innovative research projects are selected for support. The Society is currently investing $450 million dollars across 50 cancer types, for example: Grants Total Breast cancer 204 $86.4 million Lung cancer 101 $31.5 million Colon cancer 100 $32.1 million Cancer disparities 85 $72.4 million Prostate cancer 78 $28.0 million Leukemia 75 $26.2 million Childhood cancer 43 $22.5 million As of March 1, 2015. List does not include all grants funded at this time. 17 Cancer Facts & Figures Series The Society publishes the most widely cited statistics about cancer, available to the public via a series of publications: Cancer Facts & Figures Cancer Facts & Figures for African Americans Cancer Prevention & Early Cancer Facts & Figures for Detection Facts & Figures Hispanics/Latinos Breast Cancer Facts Cancer Treatment & & Figures Survivorship Facts & Figures Colorectal Cancer Facts Global Cancer Facts & & Figures Figures cancer.org/research/cancerfactsstatistics 18 6 8/12/2016 CA: A Cancer Journal for Clinicians The Society’s peer-reviewed journal, CA, publishes the latest American Cancer Society guidelines, as well as reviews articles covering many areas of oncology. Enables clinicians and healthcare professionals to offer evidence-based advice for cancer prevention and early detection. Offers a host of additional resources that enable readers to stay abreast of the latest facts, figures, and information that are essential to healthcare professionals. Is published 6 times a year in both print and online. 19 Cancer Prevention & Early Detection 50 Years Fighting Tobacco Use We know what works: Tobacco Taxes Cessation Assistance Tobacco Advertising, Promotion, & Sponsorship (TAPS) Bans Smoke-free Air Graphic Warning Labels Restricting Youth Access ACS CAN* supports comprehensive The Society’s early studies linking smoke-free laws, increased smoking with lung cancer and higher Since then, adult smoking rates tobacco taxes, funding for tobacco overall death rates contributed to the US nationwide have declined from over cessation programs, and federal Surgeon General’s first report on 40% to less than 20%. regulation of tobacco products. smoking and health in 1964. These policies have helped more than 1 million people quit smoking. * American Cancer Society Cancer Action NetworkSM is the Society's nonprofit, nonpartisan advocacy affiliate. 21 7 8/12/2016 Center for Tobacco Control Opening in 2015 to address the challenges of the changing landscape in tobacco control, including e-cigarettes, greater restrictions of sales, and new endgame strategies Working to ensure effective policies and cessation interventions to reduce tobacco use in high-burden communities Providing leadership training and development – both domestically and globally 22 Quit For Life Program The American Cancer Society partners with Alere Wellbeing to offer the Quit For Life Program. The program is offered by 27 states and more than 675 employers and health plans – more than any other tobacco cessation program.* An evidence-based combination of physical, psychological, and behavioral strategies enable participants to take responsibility for and overcome their addiction. The average quit rate among employer clients is 46% -- making the Quit For Life Program 9 times more effective than quitting without support. * As of 2013 23 We’re fighting the rising tide of tobacco use around the globe. The Tobacco Atlas is the most comprehensive, informative, and accessible resource on the pressing issues in the evolving tobacco epidemic. We are standing at a “ crossroads in the fight against Watch and learn more. tobacco. ” 24 8 8/12/2016 Saving Lives from Colon Cancer Colorectal cancer (commonly known as “colon cancer”) is the second leading cause of cancer death, when men and women are combined. Screening can both prevent colon cancer and detect cancer at an early stage, when it is most treatable. Yet about 1 in 3 adults ages 50-75 are not getting tested as recommended.* We are saving lives from colon cancer by: Promoting screening, working with physicians and underserved communities Providing information and support to patients Sponsoring cutting-edge research ACS CAN** advocates for increased access to screening and treatment * According to the Centers for Disease Control and Prevention. * American Cancer Society Cancer Action NetworkSM is the Society's nonprofit, nonpartisan advocacy affiliate. 25 Saving Lives from Breast Cancer Breast cancer is the most frequently diagnosed non-skin cancer in women, and also occurs in men. Screening can detect cancer at an early stage, when it is most treatable. The five-year survival rate for breast cancer is 99% among individuals whose cancer has not spread beyond the breast at the time of diagnosis. We are making the most impact in the fight to end breast cancer by: Promoting screening by working with physicians and underserved communities Being here 24 hours a day for you and the women you love with information, answers, and support Investing more in breast cancer research than any other cancer ACS CAN* advocating for increased funding for breast cancer research, and to ensure access to screening and treatment * American Cancer Society Cancer Action NetworkSM is the Society's nonprofit, nonpartisan advocacy affiliate. 26 Saving Lives from Breast Cancer Support is available 24/7 for those facing breast cancer. Reach To Recovery® volunteers have provided personal support to more than 1.5 million women facing breast cancer since 1969.* ACS CAN** works to increase funding for breast cancer research and ensure access to screening and treatment. * Through 2014 ** American Cancer Society Cancer Action NetworkSM is the Society's nonprofit, nonpartisan advocacy affiliate.
Load more

Recommended publications
  • Cancer Treatment and Survivorship Facts & Figures 2019-2021
    Cancer Treatment & Survivorship Facts & Figures 2019-2021 Estimated Numbers of Cancer Survivors by State as of January 1, 2019 WA 386,540 NH MT VT 84,080 ME ND 95,540 59,970 38,430 34,360 OR MN 213,620 300,980 MA ID 434,230 77,860 SD WI NY 42,810 313,370 1,105,550 WY MI 33,310 RI 570,760 67,900 IA PA NE CT 243,410 NV 185,720 771,120 108,500 OH 132,950 NJ 543,190 UT IL IN 581,350 115,840 651,810 296,940 DE 55,460 CA CO WV 225,470 1,888,480 KS 117,070 VA MO MD 275,420 151,950 408,060 300,200 KY 254,780 DC 18,750 NC TN 470,120 AZ OK 326,530 NM 207,260 AR 392,530 111,620 SC 143,320 280,890 GA AL MS 446,900 135,260 244,320 TX 1,140,170 LA 232,100 AK 36,550 FL 1,482,090 US 16,920,370 HI 84,960 States estimates do not sum to US total due to rounding. Source: Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute. Contents Introduction 1 Long-term Survivorship 24 Who Are Cancer Survivors? 1 Quality of Life 24 How Many People Have a History of Cancer? 2 Financial Hardship among Cancer Survivors 26 Cancer Treatment and Common Side Effects 4 Regaining and Improving Health through Healthy Behaviors 26 Cancer Survival and Access to Care 5 Concerns of Caregivers and Families 28 Selected Cancers 6 The Future of Cancer Survivorship in Breast (Female) 6 the United States 28 Cancers in Children and Adolescents 9 The American Cancer Society 30 Colon and Rectum 10 How the American Cancer Society Saves Lives 30 Leukemia and Lymphoma 12 Research 34 Lung and Bronchus 15 Advocacy 34 Melanoma of the Skin 16 Prostate 16 Sources of Statistics 36 Testis 17 References 37 Thyroid 19 Acknowledgments 45 Urinary Bladder 19 Uterine Corpus 21 Navigating the Cancer Experience: Treatment and Supportive Care 22 Making Decisions about Cancer Care 22 Cancer Rehabilitation 22 Psychosocial Care 23 Palliative Care 23 Transitioning to Long-term Survivorship 23 This publication attempts to summarize current scientific information about Global Headquarters: American Cancer Society Inc.
    [Show full text]
  • ACS South Atlantic Division Cancer Facts & Figures, 2007
    South Atlantic Division Cancer Facts & Figures 2007 Includes CD With State & County Data We Are Here. Making A Difference In Every Community. Delaware North Carolina District of Columbia South Carolina Georgia Virginia Maryland West Virginia South Atlantic Division, Inc. American Cancer Society Mission Statement The American Cancer Society is the nationwide, community-based, voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives and diminishing suffering from cancer, through research, education, advocacy, and service. Acknowledgements With grateful appreciation for their contribution and assistance: Delaware Cancer Registry Marjorie Shannon, MS District of Columbia Cancer Registry Aaron Adade, PhD Georgia Comprehensive Cancer Registry Rana Bayakly, MPH Maryland Cancer Registry Diane Dwyer, MD Maryland Vital Statistics Administration Hal Sommers, MA North Carolina Central Cancer Registry Karen Knight, MS; Chandrika Rao, PhD South Carolina Central Cancer Registry Susan Bolick-Aldrich, MSPH, CTR; Margaret Ehlers, MSPH Virginia Cancer Registry Jim Martin, PhD; Carolyn Halbert MA, MPH Virginia Center For Health Statistics Calvin Reynolds, Robert Magnotti West Virginia Cancer Registry Patricia Colsher, PhD, Myra Fernatt West Virginia Health Statistics Center Daniel Christy, MPA; Tom Light American Cancer Society Kathleen Wall, MSW Editor: Judy Walrath, PhD Planning Manager © 2007 American Cancer Society, South Atlantic Division, Inc. All rights reserved, including the right
    [Show full text]
  • Landmarks in Cancer Research 1907-2017
    1907 • YEARS • 2017 RESEARCH • EDUCATION • COMMUNICATION • COLLABORATION 1907 • YEARS • 2017 LANDMARKS IN CANCER RESEARCH 1907-2017 Ten years ago, the American Association for Cancer Research (AACR) marked its 100th anniversary with Landmarks in Cancer Research 1907 – 2007, a historical timeline of the seminal discoveries and events that took place in the AACR’s first century. The ensuing decade has brought a rapid escalation in the pace of progress against cancer. New drugs made it possible to treat cancer with more targeted strategies; data-sharing efforts opened doors to improved collaboration; and the nation’s leaders took aim at cancer, pledging to support innovative programs and increased funding to accelerate progress against cancer. This second edition of Landmarks in Cancer Research, therefore, stands as a tribute to the AACR’s first century and a celebration of the remarkable decade of progress that followed. We defined a Landmark as an event or discovery that has had a profound effect on advancing our knowledge of the causes, detection, diagnosis, treatment, or prevention of cancer. To develop our timeline, we convened a committee that included some of the world’s leading cancer researchers and advocates. Our final selections are based on research, historical analysis, active discussion, and rigorous scientific review, and as we pointed out 10 years ago, this list is inherently incomplete. The Landmark yet to be discovered may change a patient’s life tomorrow. The scientific community is relentless in its quest to prevent and cure all cancers, and each Landmark is the culmination of years of hard work, often by teams of researchers, physician-scientists, policy makers, and advocates.
    [Show full text]
  • The Costs of Cancer Addressing Patient Costs Introduction
    Cancer Action Network SM The Costs of Cancer Addressing Patient Costs Introduction Cancer is one of the leading causes of death and disease in the U.S. The American Cancer Society (ACS) estimates that roughly 1.7 million new cases of cancer will be diagnosed in the U.S. in 20171 and more than 15 million Americans living today have a cancer history.2 Not only does cancer take an enormous toll on the health of patients and survivors—it also has a tremendous financial impact. For patients and their families, the costs associated with direct cancer care are staggering. In 2014 cancer patients paid nearly $4 billion out-of-pocket for cancer treatments. Cancer also represents a significant proportion of total U.S. health care spending. Roughly $87.8 billion was spent in 2014 in the U.S. on cancer-related health care.3 These costs were paid by employers, insurance companies, and taxpayer-funded public programs like Medicare and Medicaid, as well as by cancer patients and their families. Total U.S. Expenditures for Cancer by Source of Payment—2014 Other* 15% Medicaid 4% Patient Out-of-Pocket Costs = $3.9 billion 4% 44% Private Insurance 33% Medicare Source: MEPS4 * The relative standard error for this category was greater than 30 percent. See reference for definition of “other.”5 Total U.S. Expenditures for Cancer by Type of Service—2014 Home Health Prescribed Medicines* 2% 12% Emergency Room Visits* 1% Hospital Inpatient 27% Stays 58% Hospital Outpatient or Office-Based Provider Visits Source: MEPS6 * The relative standard error for this category was greater than 30 percent.
    [Show full text]
  • Treating Non-Hodgkin Lymphoma If You’Ve Been Diagnosed with Non-Hodgkin Lymphoma, Your Treatment Team Will Discuss Your Options with You
    cancer.org | 1.800.227.2345 Treating Non-Hodgkin Lymphoma If you’ve been diagnosed with non-Hodgkin lymphoma, your treatment team will discuss your options with you. It’s important to weigh the benefits of each treatment option against the possible risks and side effects. How is non-Hodgkin lymphoma treated? Depending on the type and stage (extent) of the lymphoma and other factors, treatment options for people with NHL might include: ● Chemotherapy for Non-Hodgkin Lymphoma ● Immunotherapy for Non-Hodgkin Lymphoma ● Targeted Drug Therapy for Non-Hodgkin Lymphoma ● Radiation Therapy for Non-Hodgkin Lymphoma ● High-Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin Lymphoma ● Surgery for Non-Hodgkin Lymphoma Common treatment approaches Treatment approaches for NHL depend on the type of cancer, how advanced it is, as well as your health and other factors. Another important part of treatment for many people is palliative or supportive care. This can help prevent or treat problems such as infections, low blood cell counts, or some symptoms caused by the lymphoma. ● Treating B-Cell Non-Hodgkin Lymphoma ● Treating T-Cell Non-Hodgkin Lymphoma ● Treating HIV-Associated Lymphoma 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 ● Palliative and Supportive Care for Non-Hodgkin Lymphoma Who treats non-Hodgkin lymphoma? Based on your treatment options, you may have different types of doctors on your treatment team. These doctors could include: ● A medical oncologist or hematologist: a doctor who treats lymphoma with chemotherapy, immunotherapy, and targeted therapy. ● A radiation oncologist: a doctor who treats cancer with radiation therapy. ● A bone marrow transplant doctor: a doctor who specializes in treating cancer or other diseases with bone marrow or stem cell transplants.
    [Show full text]
  • Treating Non-Small Cell Lung Cancer
    cancer.org | 1.800.227.2345 Treating Non-Small Cell Lung Cancer If you've been diagnosed with non-small cell lung cancer (NSCLC), your cancer care team will discuss your treatment options with you. It's important to weigh the benefits of each treatment option against the possible risks and side effects. How is non-small cell lung cancer treated? Treatments for NSCLC can include: ● Surgery for Non-Small Cell Lung Cancer ● Radiofrequency Ablation (RFA) for Non-Small Cell Lung Cancer ● Radiation Therapy for Non-Small Cell Lung Cancer ● Chemotherapy for Non-Small Cell Lung Cancer ● Targeted Drug Therapy for Non-Small Cell Lung Cancer ● Immunotherapy for Non-Small Cell Lung Cancer ● Palliative Procedures for Non-Small Cell Lung Cancer Common treatment approaches The treatment options for non-small cell lung cancer (NSCLC) are based mainly on the stage (extent) of the cancer, but other factors, such as a person’s overall health and lung function, as well as certain traits of the cancer itself, are also important. In many cases, more than one of type of treatment is used. ● Treatment Choices for Non-Small Cell Lung Cancer, by Stage Who treats non-small cell lung cancer? You may have different types of doctors on your treatment team, depending on the 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 stage of your cancer and your treatment options. These doctors could include: ● A thoracic surgeon: a doctor who treats diseases of the lungs and chest with surgery ● A radiation oncologist: a doctor who treats cancer with radiation therapy ● A medical oncologist: a doctor who treats cancer with medicines such as chemotherapy, targeted therapy, and immunotherapy ● A pulmonologist: a doctor who specializes in medical treatment of diseases of the lungs Many other specialists may be involved in your care as well, including nurse practitioners, nurses, psychologists, social workers, rehabilitation specialists, and other health professionals.
    [Show full text]
  • August 17, 1993, NIH Record, Vol. XLV, No. 17
    August 17, 1993 Vol.XLVNo. 17 "Still U.S. Department of Health The Second and Human Services Best Thing National Institutes of About Payday" Health Nobelist Is Clinton's Choice Max Cooper To Deliver Harold Varmus Nominated as 14th NIH Director NIAID's Kinyoun Lecture resident Clinton on Aug. 3 announced nternatio~ally recognized fo~ his pioneer­ his intention to nominate Dr. Harold ing work m developmental 1mmuno­ PEliot Varmus as the 14th director of Ibiology, Dr. Max D. Cooper will deliver rhe National lnsrituces of Health. A Senare che Kinyoun Lecture on Sept. I at 4 p.m. in confirmation process must precede Varmus' Bldg. lO's Lipsett Amphitheater. He has citied caki ng over leadership of the institutes. the talk «Lymphocyte Differentiation Pathways: Winner of che Nobel Prize in 1989 for his Changing Paradigms." work in cancer research, Varmus, 53, is a The topic derives from research in which he professor of microbiology, biochemistry, and showed that the human immune system can be biophysics, and the American Cancer Society divided developmentally and functionally into B professor of molecular virology at the Univer­ cell and T cell populations. This work was che sity of California, San Francisco. He is a leader major breakthrough in our understanding of the in the smdy of cancer-causing genes called mechanisms of immunodeficiencies and has "oncogenes," and an internationally recognized since led to a classification system and treatment authority on retroviruses, the viruses char cause advances for these illnesses. Cooper was also AIDS and many cancers in animals. responsible for pivotal insights into the process Varmus would be the first NIH director to regulating the formation of lymphoid neoplasia.
    [Show full text]
  • Benefits of Drugs with NIH Research Involvement
    The Benefits of Medical Research and the Role of the NIH May 2000 Office of the Chairman, Connie Mack http://jec.senate.gov THE BENEFITS OF MEDICAL RESEARCH AND THE ROLE OF THE NIH May 17, 2000 THE BENEFITS OF MEDICAL RESEARCH AND THE ROLE OF THE NIH EXECUTIVE SUMMARY The NIH Leads the Battle Against Disease ! Leading the battle against disease. As the world’s leading medical research institution, the NIH funds more than 35,000 research grants each year to scientists across the country making advances against heart disease, cancer, and many other diseases. NIH-funded scientists have won 93 Nobel Prizes over the years, and researchers in the NIH’s own labs have won 5 Nobel Prizes. ! High returns from federal investments. The federal government, mainly through the NIH, funds about 36 percent of all U.S. medical research. Most NIH-funded research focuses on basic science, which creates advances across many disease categories. Publicly funded research in general generates high rates of return to the economy, averaging 25 to 40 percent a year. ! Successes against many diseases. NIH-funded research has contributed to dramatic decreases in heart disease and stroke mortality rates, increased cancer survival rates, new medications for mental illness, vaccines to protect against infectious diseases, and many other advances in medicine. ! NIH behind 7 of 21 top drugs. Of the 21 most important drugs introduced between 1965 and 1992, 15 were developed using knowledge and techniques from federally funded research. Of these, NIH research led to the development of 7 drugs used to treat patients with cancer, AIDS, hypertension, depression, herpes, and anemia.
    [Show full text]
  • American Cancer Society, Cancer Facts & Figures-1998
    F&F98.wpc 6/12/01 8:04 PM Page a sV~,i~h¶~NI -CANCEB SIP,IAMERICANCAN CER f SOCIETY® FACTS & FIGURES-1998 HI PR * 4 44040 4---300 C"• 11,'00 The American Cancer Son acknowledges a generous grant to the American Cancer Society FoundationGlaxo-Wefl by GlaxoWellcome. '3. , - F&F98.wpc 6/12/01 8:04 PM Page b I CONTENT Cancer: Basic Facts ......................... 1 Cancer Around the World* ................... 19 Age-Adjusted Cancer Death Rates, Males by Site* ... 2 Special Section: Prostate Cancer ............... 20 Age-Adjusted Cancer Death Rates, Prostate Cancer-Age-Specific Incidence Fem ales by Site* ............................ 3 and Mortality Rates by Race* ................. 20 Estimated New Cancer Cases and Deaths Prostate Cancer--Incidence and Mortality Rates by Sex for All Sites* ......................... 4 by Race and Ethnicity* ...................... 21 Estimated New Cancer Cases, by State* .......... 5 Prostate Cancer--Incidence and Mortality Rates Estimated Cancer Mortality, by State* ............ 6 by R ace* ................................. 22 20-Year Trends in Cancer Death Rates* ........... 7 Prostate Cancer-5-Year Relative Survival Rates by Selected Cancers .......................... 8 .Stage and Percent Diagnosed by Stage and Race* ... 23 Leading Sites of New Cancer Cases and Deaths* .... 9 Tobacco U se .............................. 25 How to Estimate Cancer Statistics Locally* ....... 10 Nutrition and Diet .......................... 29 Pecentage of Population (Probability) Environmental Cancer Risks ................. 30 Developing Invasive Cancers* ................. 11 Summary of American Cancer Society Five-Year Relative Survival Rates Recommendations for the Early Detection by Stage at Diagnosis* ....................... 14 of C ancer* ............................... 31 Trends in Five-Year Relative Survival Rates The American Cancer Society ................ 32 by Race and Year of Diagnosis* ...............
    [Show full text]
  • Special Section: Cancer in Adolescents and Young Adults
    Special Section: Cancer in Adolescents and Young Adults Overview In this special section, we provide an overview of trends in cancer incidence, mortality, and survival and discuss In 2020, there will be approximately 89,500 new cancer some of the unique challenges among AYAs. In order to cases and 9,270 cancer deaths in adolescents and young fully describe the heterogeneity in the disease burden adults (AYAs) ages 15 to 39 years in the United States within AYAs, cancer occurrence is also described (Table S1). These patients are often grouped with younger separately by age group. or older patient populations, which masks important differences in cancer distribution, tumor biology, and survivorship. For example, an increasing body of Leading cancers in AYAs evidence indicates that several types of cancer in AYAs The most common cancers among AYAs vary are molecularly distinct from those that occur in other substantially by age and are shown in Figure S1. age groups, suggesting possible differences in how Adolescents (15- to 19-year-olds) have a unique cancer cancers in this age group develop and are most effectively profile that includes childhood cancers (e.g., acute treated.1, 2 In addition, for some cancer types, AYAs are lymphocytic leukemia), adult cancers (e.g., thyroid and more likely to be diagnosed at a late stage because of both melanoma of the skin), and a disproportionately high delays in diagnosis due to the rarity of cancer in this age burden of lymphoma. For example, Hodgkin lymphoma group and higher uninsured rates and higher prevalence accounts for 13% of cancer cases in adolescents of aggressive disease.3, 4 AYA patients also have a high risk compared to 9% in ages 20-29 years and 3% in ages 30-39 of long-term and late effects, including infertility, sexual years.11 Conversely, adults 20-39 years have a higher dysfunction, heart problems, and future cancers.5-8 proportion of solid tumors.
    [Show full text]
  • Prevention & Early Detection Facts & Figures 2019-2020
    Cancer Prevention & Early Detection Facts & Figures 2019-2020 Current* Cigarette Smoking (%), Adults 18 Years and Older by State, 2017 WA NH ME MT ND VT OR MN ID MA SD WI NY WY MI RI IA PA CT NV NE OH NJ UT IL IN CA DE CO WV KS VA MD MO KY DC NC TN AZ OK NM AR SC MS AL GA TX LA AK FL 22% to 26% 18% to 21% PR 15% to 17% HI 9% to 14% *Smoked 100 cigarettes in lifetime and are current smokers (regular and irregular). Source: Behavioral Risk Factor Surveillance System, 2017. Contents Introduction 1 Infectious Agents 32 References 1 Human Papillomavirus 32 Highlights, CPED 2019-2020 1 Helicobacter Pylori 34 Hepatitis B Virus 35 Tobacco 2 Hepatitis C Virus 37 Cigarette Smoking 2 Human Immunodeficiency Virus 38 Other Combustible Tobacco Products 3 Epstein-Barr Virus 38 E-cigarettes (Vaping Devices) 4 References 38 Smokeless Tobacco Products 7 Secondhand Smoke 7 Occupational and Environmental Cancer Tobacco Cessation 8 Risk Factors 40 Reducing Tobacco Use and Exposure 9 Occupational Cancer Risk Factors 41 References 12 Environmental Cancer Risk Factors 41 Conclusions 44 Excess Body Weight, Alcohol, Diet, References 44 and Physical Activity 14 Excess Body Weight 14 Cancer Screening 45 Alcohol 16 Breast Cancer Screening 45 Diet 18 Cervical Cancer Screening 48 Physical Activity 21 Colorectal Cancer Screening 50 Type 2 Diabetes 22 Lung Cancer Screening 53 Community Action 22 Prostate Cancer Screening 53 References 25 Endometrial Cancer Screening 54 Cancer Screening Obstacles and Opportunities to Ultraviolet Radiation 27 Improve Utilization 54 Solar UVR Exposure 27 American Cancer Society Recommendations for the Early Artificial UVR Exposure (Indoor Tanning) 27 Detection of Cancer in Average-risk Asymptomatic People* 55 UVR Exposure and Protective Behaviors 28 References 57 Prevention Strategies in Skin Cancer 29 Special Notes 58 Early Detection of Skin Cancer 30 Glossary 58 References 31 Survey Sources 59 Global Headquarters: American Cancer Society Inc.
    [Show full text]
  • A Helping Hand: the 2021 Resource Guide for People with Cancer 1 Introduction Cancercare’S Publications Knowledge Is a Powerful Tool to Help People Cope with Cancer
    A Helping A FINANCIAL HELP Hand INFO/EDUCATION The 2021 Resource Guide for People With Cancer With People Guide for Resource The 2021 A Helping Hand The 2021 Resource Guide for People With Cancer SPECIAL POPULATIONS SERVICES National Office 275 Seventh Avenue New York, NY 10001 CANCER TYPES Table of Contents Acknowledgements Introduction 3 This activity is supported by Bristol Myers Squibb and a grant Taking Control of Your Finances 5 from Genentech. CancerCare would also like to acknowledge the Cancer Financial Sources of Financial Assistance 7 Assistance Coalition (CFAC) for its collaborative efforts in sharing resources and educating patients and providers about financial Finding Help in Your Community 11 issues. Getting Help From Advocacy Organizations 12 © 2021 CancerCare® CancerCare® A Guide to the “Helping Hand” Categories 15 National Office 275 Seventh Ave. National Assistance Organizations 17 New York, NY 10001 800-813-HOPE (4673) Regional Assistance Organizations 92 www.cancercare.org Indices 229 CancerCare relies on the generosity of supporters to provide our services completely free of charge to anyone affected by Index of National Organizations cancer. If you have found this resource helpful and wish to by Cancer Type 229 donate, please visit www.cancercare.org/donate. You may also mail a check, payable to CancerCare, to: CancerCare®, Attn: Donations, 275 Seventh Ave., New York, NY 10001. Index of National Organizations by Service Type 233 What did you think of this publication? Tell us at [email protected]. Index of National Organizations by Info/Education 237 Index of National Organizations by Special Populations 239 Please note: Mention in this publication does not imply endorsement on the part of CancerCare.
    [Show full text]